In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part I: beyond the reduction of animal model use

被引:15
作者
Huynh, Lucie [2 ]
Masereeuw, Rosalinde [3 ]
Friedberg, Thomas [4 ,5 ]
Ingelman-Sundberg, Magnus [6 ]
Manivet, Philippe [1 ,7 ,8 ,9 ]
机构
[1] Hop Lariboisiere, APHP, Serv Biochim & Biol Mol, Unite Biol Clin Struct, F-75475 Paris 10, France
[2] ADME T Modeling Platform, Div Struct Biol, Paris 05, France
[3] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, Nijmegen, Netherlands
[4] Ninewells Hosp, Biomed Res Ctr, Canc Res UK Mol Pharmacol Unit Level 5, Dundee, Scotland
[5] Univ Dundee, Sch Med, Dundee DD1 4HN, Scotland
[6] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden
[7] Univ Paris 05, UFR Sci Pharmaceut & Biol, Paris 06, France
[8] Mahidol Univ, Fac Pharm, Dept Microbiol, FTMMU, Bangkok 10700, Thailand
[9] Univ Evry Val dEssone, INSERM, U829, Evry, France
关键词
PHARMACOKINETICS; METABOLISM; ABSORPTION; BINDING; PROTEIN; TOX;
D O I
10.1016/j.drudis.2009.01.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is an urgent need for efficient in silico ADME-T prediction tools for the selection of potent therapeutic drugs as well as the elimination of toxic compounds. This is particularly important in view of the high costs and ethical issues inherent to the use of animal models for drugs filtering. To achieve this mission, not only does the accuracy of in silico tools need to be improved, but also new experts in the field with skills in theoretical. chemistry, clinical and fundamental biology have to be trained. Similarly, clinical biologists committed to the obligation of means and legally responsible for the results they generate could establish a legal framework that defines legal responsibilities when performing in silico predictions.
引用
收藏
页码:401 / 405
页数:5
相关论文
共 16 条
[1]   Competitive CYP2C9 inhibitors:: Enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis [J].
Afzelius, L ;
Zamora, I ;
Ridderström, M ;
Andersson, TB ;
Karlén, A ;
Masimirembwa, CM .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :909-919
[2]   In silico prediction of ADME and pharmacokinetics - Report of an expert meeting organised by COST B15 [J].
Boobis, A ;
Gundert-Remy, U ;
Kremers, P ;
Macheras, P ;
Pelkonen, O .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 17 (4-5) :183-193
[3]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[4]   Population modelling to describe pharmacokinetics of amiodarone in rats:: Relevance of plasma protein and tissue depot binding [J].
Campos Moreno, Eduardo ;
Merino Sanjuan, Matilde ;
Merino, Virginia ;
Nacher, Amparo ;
Martin Algarra, Rafael V. ;
Casabo, Vicente G. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 30 (02) :190-197
[5]   Benomyl and Colchicine Synergistically Inhibit Cell Proliferation and Mitosis: Evidence of Distinct Binding Sites for These Agents in Tubulin [J].
Clement, Marie-Jeanne ;
Rathinasamy, Krishnan ;
Adjadj, Elisabeth ;
Toma, Flavio ;
Curmi, Patrick A. ;
Panda, Dulal .
BIOCHEMISTRY, 2008, 47 (49) :13016-13025
[6]   The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools [J].
De Buck, Stefan S. ;
Sinha, Vikash K. ;
Fenu, Luca A. ;
Gilissen, Ron A. ;
Mackie, Claire E. ;
Nijsen, Marjoleen J. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) :649-659
[7]  
GIACOMINI KM, 2005, MEMBRANE TRANSPORTER, P41
[8]  
HONIQ M, 2005, CHEM INF MODEL, V45, P1169
[9]   Validity and validation of expert (Q)SAR systems [J].
Hulzebos, E ;
Sijm, D ;
Traas, T ;
Posthumus, R ;
Maslankiewicz, L .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2005, 16 (04) :385-401
[10]   Applying computational modeling to drug discovery and development [J].
Kumar, Neil ;
Hendriks, Bart S. ;
Janes, Kevin A. ;
de Graaf, David ;
Lauffenburger, Douglas A. .
DRUG DISCOVERY TODAY, 2006, 11 (17-18) :806-811